Proposal of a scoring scale as a survival predictor in intracranial oligodendrogliomas
- 36 Downloads
Histological, clinical and radiological features, and molecular genetic analysis are among the factors that have been considered in defining the prognosis of oligodendrogliomas (OD), but they have yielded conflicting results.
The purpose of this study was to test out a scoring scale based on clinical, radiological, pathological and molecular features.
Material and method
To identify factors with prognostic significance, we analyzed 87 treated patients with a histological diagnosis of OD. Of the parameters analyzed, age, onset, clinical status, radiological enhancement, histological necrosis, mitosis and chromosomal anomalies emerged as significant prognosis factors using univariate analysis. Multivariate analysis revealed age and chromosomal anomalies as independent factors of survival.
The factors with a significant prognostic value were combined to determine which grouping factors best predict outcome. The proposed score is a pure number resulting from a combination of: 2 major factors: age and chromosomal anomalies (scored 3–0); 5 minor factors: onset, clinical examination, necrosis, mitoses (scored 1–0), and radiological enhancement (scored 2–0). According to our scale, 10 survival curves were produced for overall survival. Recursive partitioning of patients with the nearest score and outcome produced four groups with a significant difference in survival (p=10−5). The power of both the scale and the partitioned groups for predicting outcome was more accurate than the WHO and St Anne grading systems, and the molecular sub-classification.
Our scale is a plausible way of classifying patients harboring intracranial OD according to expected survival.
Keywordsgrading intracranial tumor oligodendroglioma prognosis scale
Unable to display preview. Download preview PDF.
We are grateful to Abed El-Ghalem for his help and advice and Ms. T. Westcott for correcting the English. In memory of Larbi Hamlat.
- 23.Giammarile F, Cinotti LE, Jouvet A, Ramackers JM, Saint Pierre G, Thiesse P, Jouanneau E, Guyotat J, Pelissou-Guyotat I, Setiey A, Honnorat J, Le Bars D, Frappaz D, High and low grade oligodendroglioma(ODG): correlation of amino-acid and glucose uptakes using PET and histological classifications J Neuro-Oncol68:263–274; 2004CrossRefGoogle Scholar
- 30.Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN, Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas J Natl Cancer Inst90:1473–1479; 1998PubMedCrossRefGoogle Scholar
- 31.Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, Von Deimling A, Pomeroy SL, Golub TR, Louis D, Gene expression-based classification of malignant gliomas correlates better with survival than histological classification Cancer Res63:1602–1607; 2003PubMedGoogle Scholar
- 39.Smith JS, Alderete B, Minn Y, Borell TJ, Perry A, Mohapatra G, Hosek SM, Kimmel D, O’Fallon J, Yates A, Feuerstein BG, Burger PC, Scheithauer BW, Jenkins RB, Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype Oncogene18: 4144–4152; 1999PubMedCrossRefGoogle Scholar
- 43.Kearney L Molecular cytogenetics Best Practice & ResearchClin Haematol 14:645–668; 2001Google Scholar